who were diagnosed as suffering from cryptococcosis of the nervous system in Queensland, Australia, over the nine year period 1 November 1959 to 31 October 1968. Only one of these patients, a female who developed cryptococcal meningitis during a pregnancy, has been previously reported (Kuo, 1962) . Certain epidemiological factors are discussed and reference is made to factors which may be important in the chain of aetiology. The clinical features of neurological cryptococcosis are reviewed with particular reference to early diagnosis. The efficacy and hazards of modern therapy are assessed. (Fig. 1 ).
METHODS
Cryptococcosis is not a notifiable disease in Queensland; neurological cryptococcosis is a serious condition requiring specialized investigation and treatment, so that as a rule patients are ultimately admitted to one of the major hospitals at Brisbane, Cairns, Mount Isa, Rockhampton, Toowoomba, and Townsville. The records departments of these hospitals were contacted and then one of us (V.E.E.) visited these centres and studied the case histories and, when indicated, the necropsy reports of all patients found who had suffered from cryptococcosis of the nervous system over the period 1 November 1959 to 31 October 1968. We think that in this way practically all patients in Queensland who developed neurological cryptococcosis during the survey period have been documented. With one exception, all surviving patients have been personally examined by V.E.E. The remaining surviving patient now resident in Tasmania, was examined on our behalf by medical personnel of the Repatriation Department.
RESULTS

CLINICAL ASPECTS
CASE SERIES The case series is summarized in Table  I and comprised 29 patients suffering from cryptococcosis of the nervous system. Table 5 the incidence of neurological cryptococcosis in these two racial groups is compared. The overall nine years ascertainment rate for Queensland was Although the onset of neurological cryptococcosis is sometimes acute, it was generally insidious and the progress slow rather than rapid. However, as will be seen from Table 8 , the diagnosis in the 24 patients in whom the disease was discovered during life was generally made within a few weeks to a month or two from the time the patient started to experience relevant symptoms. The symptoms which occurred early and late in the present series are listed in Table 9 . Headache was the outstanding symptom and was often associated with nausea or vomiting. Fever was absent in some patients and in only about one-third of cases did the presence of neck stiffness suggest meningeal irritation.
Apart from papilloedema, which was not often present in the early stages, visual symptoms, other cranial nerve lesions, long tract signs, and changes in consciousness did not usually occur until late in the disease process. The typical early presentation was an adult patient complaining of increasing headaches of a few weeks' duration who did not look well. The diagnosis of neurological cryptococcosis was usually confirmed by examination of the cerebrospinal fluid. Since cryptococcus neoformans is the only encapsulated yeast which invades the nervous system, demonstration of the oval encapsulated fungus by indian ink preparations was sufficient justification for initiating therapy while the diagnosis was being confirmed by culture and mouse inoculation.
The results of examination of the cerebrospinal Geaney, Horsfall, and Neilson (1956) all died from the disease. In the present series of 29 patients, 24 were diagnosed during life as having cryptococcosis of the nervous system. All these 24 patients were given amphotericin B. Of these, as will be seen from appears that intravenous therapy alone can be successful, but in seriously ill patients both intravenous and intrathecal routes should be used. The three patients who died from cryptococcosis were given amphotericin B intravenously and intrathecally but it is probable that the fatal outcome is a reflection of the serious state they were in at the time of treatment rather than an indication of increased toxicity of the drug when given intrathecally. Amphotericin B is given by intravenous infusion in adose of 1 mg/kg of body weight in a 5% solution of dextrose in water, over a period of six hours, daily or every second day, for a period of six weeks to three months. It is generally advisable to commence treatment with 1 mg in 250 ml. 5 % dextrose and thereafter to increase the dose by 5 to 10 mg each day (at the same time increasing the volume of 5% dextrose) until 1 mg/kg of body weight is being given (Andrioli and Krauetz, 1962) . For intrathecal administration of amphotericin B, lumbar puncture is performed and 5 ml. cerebrospinal fluid are withdrawn into an appropriate syringe. The fluid is mixed with 15 to 20 mg hydrocortisone and is then slowly injected intrathecally. Several minutes later 5 ml. cerebrospinal fluid may again be withdrawn and mixed with 2-5 ml. of a solution containing 0-25 to 0 5 mg amphotericin B in 5% glucose and water. This mixture is then slowly injected into the lumbar subarachnoid space. The procedure may be repeated two or three times each week until a total of 15 mg amphotericin B has been given intrathecally.
Although amphotericin B is effective in the treatment of this otherwise fatal condition, sideeffects of the drug are commonly encountered. Gear and Newton (1969) only one child, an African aged 9 years of age, suffered from cryptococcosis of the nervous system, while another 9-year-old African child had femoral osteitis from which C. neoformans was isolated (Bubb, 1955) . Our fiindings are thus in agreement with the opinion expressed by Brody (1969) that the majority of patients suffering from neurological cryptococcosis are adult males.
In the present survey, 20 of the 29 patients were regarded as having outdoor occupations and of these 12 worked with livestock (cattle) or poultry. Because C. neoformans has been recovered from soil and from various animals and birds, it seemed possible that occupational exposure could be an important link in the chain of aetiology. McCall (1969) pointed out that the age distribution in this and in other series would favour an occupational risk rather than a soil reservoir of infection, which would have been more readily incriminated had the majority of patients been in the first decade of life. Although Littman and Zimmerman (1956) felt that occupation seemed to play little part in the incidence of the disease, in a later paper Littman and Walter (1968) , emphasizing the high prevalence of the fungus in the excreta of domesticated and feral pigeons, felt that it was not unreasonable to consider cryptococcosis as an occupational hazard. C. neoformans is certainly found in the soil (Emmons, 1955; MacGillivray, 1964) and in the excreta of birds, especially pigeons (Littman and Schneierson, 1959; Frey and Durie, 1964) ; the fungus has been recovered from various animals (Littman and Zimmerman, 1956 ), including cattle (Simon, Nichols, and Morse, 1953) and even the koala (Bolliger and Finckh, 1962) . In view of this widespread distribution in nature, it is probable that many people inhale the fungus without ill effects (Annotation, Lancet, 1969) and Cox and Tolhurst (1946) considered it was possible that individual susceptibility or resistance might play an important role. This concept is supported by the concurrence of cryptococcosis of the nervous system with other disorders which might disturb immune responses (Zimmerman and Rappaport, 1954) and with long-continued steroid therapy which, in a similar way, also predisposes the individual to infection (Goldstein and Rambo, 1962) . In the present series, seven patients suffered from a disease in addition to cryptococcosis and four patients were receiving steroid therapy when they developed evidence of the infection. It is, however, considered possible that clinical cryptococcosis may also result from repeated exposure to the infection or to individual exposure to an overwhelming infection and that rural residence and occupation may be important in this regard. Littman and Zimmerman (1956) considered that there was no greater susceptibility to cryptococcosis in dark-skinned races than in white-skinned races, and Littman and Walter (1968) suggested that pulmonary cryptococcosis appeared to have a marked predilection for the white man. However, in Australia, four of the 14 patients reported by Geaney et al. (1956) were aboriginals and Crotty (1965) considered that 0 5 to 1 % of deaths in aboriginals in the Northern Territory resulted from cryptococcal meningitis. In the present series of 29 patients, five were coloured, furnishing a nine years incidence rate of 25 9 per 100,000 compared with 1 5 per 100,000 for those of European extraction. We are indebted to Gear and Newton (1969) who furnished us with the following information from South Africa: they encountered 14 patients with cryptococcosis in the South African literature, and in their own experience, of whom five were European, seven African, one 'coloured', and one Indian.
It is established that neurological cryptococcosis occurs in dark and white races and that in Queensland there is a relatively high incidence of the disease in the aboriginal as well as the white population. The possibility that the higher incidence in the aboriginal can be correlated with geographical and occupational factors needs further study, especially as the aboriginal population tends to live in country districts and work at rural occupations in the north and west of the State.
Reference has already been made to the fact that cryptococcosis of the nervous system would appear to be more common in Australia than in the United Kingdom, although the population of Australia is predominantly of British stock. Cases reported in the Australian literature from 1935 to the present time are indicated in Table 15 . This should not be taken to indicate the prevalence of the disease in the various states but it does suggest a relatively high incidence of cryptococcosis, an incidence which cannot be wholly accounted for by a possible increased susceptibility in the Australian aboriginal.
The results of the present survey also indicate that neurological cryptococcosis is more prevalent in tropical north Queensland than in the more temperate south, so that of the 29 patients in the series, 17 were living in the north when they developed the disease (a nine years incidence rate of4 7 per 100,000) compared with a nine year incidence rate of 1'8 per 100,000 in South Queensland. The geographical features of cases reported by Geaney et al. (1956) in Queensland was very similar in that at least six of their 14 patients acquired the disease in the north Crotty (1965) of the State. These authors also refer to two of their patients (aboriginals) coming from the same mission station near Cairns and a third aboriginal patient derived from a settlement, near Rockhampton, as did a fourth patient not included in their series. Numbers are too few to allow one to speak of 'pockets' of infection but the geographical distribution of cases in the present series might indicate areas in North Queensland where there is a relatively high incidence of the disease. The importance of a high environmental exposure to the fungus was also suggested by Muchmore, Rhoades, Nix, Felton, and Carpenter (1963) who found a high occurrence of C. neoformans in the environment of three geographically associated patients suffering from cryptococcal meningitis in a population of 3,204 people residing near a bird sanctuary. Available evidence would suggest that in Australia there is an animal, rather than a bird, reservoir of the fungus, and that occupational exposure and dry, dusty conditions which would predispose to massive inhalation of C. neoformans, are important factors in the aetiology of the disease. Individual susceptibility, perhaps racial, probably plays a part and, as in other regions, development of the clinical disease is predisposed to by disorders such as the reticuloses or by long-continued steroid therapy.
Cryptococcosis of the nervous system may present clinically with symptoms suggestive of cerebral neoplasm, cerebral abscess, chronic subdural haematoma, chronic meningitis of any variety including tuberculosis and brucellosis, sarcoidosis, neurosyphilis, lymphocytic choriomeningitis, leu-kaemic infiltration of meninges and meningeal carcinomatosis. Further, the neurological disorder may be obscured by an associated coexistent disease such as one of the reticuloses, leukaemia, or diabetes mellitus (Zimmerman and Rappaport, 1954; Littman and Walter, 1968) . In our experience, clinical evidence of meningitis occurred in only one-third of the cases. Similarly, fever may be inconspicuous throughout the illness. Headache of insidious onset, sometimes intermittent in the early stages, but becoming continuous and progressively more severe, is the outstanding symptom, and a patient 'who does not look well', the outstanding physical sign.
In a patient suspected of having neurological cryptococcosis, the diagnosis is established by identifying C. neoformans in the cerebrospinal fluid by indian ink examination and subsequently by culture and mouse inoculation. Serological antibody tests have been devised but, since C. neoformans may lead a saprophytic existence in the lungs and elsewhere and since these tests have furnished negative results despite the known presence of the fungus, they must be regarded as being of doubtful value at the present time. The only proof of active disseminated cryptococcal infection is the demonstration of the fungus in the cerebrospinal fluid, blood or urine (Annotation, Lancet, 1969) .
Our experience, however, suggests that C. neoformans may be difficult to detect in the lumbar cerebrospinal fluid even in patients with active or advanced involvement of the nervous system. Thus, in five patients we were unable to detect the fungus even on repeated examinations of the lumbar cerebrospinal fluid, the organism being identified, however, on direct examination of the ventricular cerebrospinal fluid. It is therefore suggested that in any suspected case-and perhaps particularly since an intracranial expanding lesion so often enters into the differential diagnosis-ventriculography with examination of the cerebrospinal fluid by indian ink technique (and culture) at the same time, is the most efficient way of establishing the correct diagnosis.
Although it has been correctly suggested that amphotericin B therapy should be withheld until there is evidence that cryptococcal infection has become disseminated (Tynes, Mason, Jennings, and Bennett, 1968; Warr, Bates, and Stone, 1968) , it must be emphasized that neurological cryptococcosis is evidence of disseminated infection and constitutes a definite indication for amphotericin B therapy. The fact that the drug is expensive, its administration unpleasant for the patient and for the doctor, and involves a prolonged regime of careful surveillance, does not detract from the value of amphotericin B, which is the only effective therapy for neurological cryptococcosis at the present time. Spickard, Butler, Andriole, and Utz (1963) Before the introduction of amphotericin B, the outlook in neurological cryptococcosis was almost uniformly hopeless. Cox and Tolhurst (1946) considered that 'nothing is known that influences its course favourably' and Littman and Zimmerman (1956) believed that 'permanent cures are extremely rare if obtained at all'. The one hundred per cent mortality in the 14 patients reported from Queensland before amphotericin B was available (Geaney et al., 1956 ) supports these views.
Despite the suggestion that amphotericin B given intravenously in safe dosage does not achieve significant drug levels in the cerebrospinal fluid (Rubin and Furcolow, 1958) , seven of the nine patients thus treated in this series were alive and well at the end of the survey period and another patient was believed to be alive but could not be traced. The present findings are in agreement with the views of Witorsch, Williams, Ommaya, and Utz (1965) that many and perhaps the majority of patients suffering from cryptococcal meningitis require only intravenous therapy. Intrathecal administration of amphotericin B should be reserved for cases in relapse or for those who are critically ill from the disease when first seen. In such cases, the drug can be given by lumbar or cistemal puncture or, if available, the Ommaya reservoir which permits of repeated intraventricular administration would seem to have much to commend it (Ommaya, 1963; Witorsch et al., 1965) .
Although in this series of patients side-effects of amphotericin B therapy occurred in more than half of the 19 patients who received adequate treatment, these can be minimized by employing smaller doses of the drug, by reducing the rate of administration, by giving the drug on alternate days as suggested by Battock, Grausz, Bobrowsky, and Littman (1968) , and by the concurrent use of steroids or an antihistamine. The blood urea became elevated in all cases during treatment but as previously indicated there was no clinical or laboratory evidence of permanent damage to kidneys, liver, or the haemopoetic system at the end of the survey period. However, our tests of liver function were relatively insensitive and, as shown by McCurdy, Frederic, and Elkington (1968) , a tubular defect in acid excretion superimposed on a kidney rendered ischaemic by renal vasoconstriction appears to underlie the hypokalaemia and nephrocalcinosis characteristic of amphotericin B nephropathy.
Two further factors merit consideration in the treatment of neurological cryptococcosis. In a number of patients an underlying associated disease such as Hodgkin's disease, reticulosis, leukaemia, or diabetes mellitus may be present. These conditions which require their own specific treatment may, of course, materially alter the outcome of the case. Secondly, complications of chronic meningitis may develop. Thus, Lethlean and Gye (1969) have emphasized the importance ofconsidering a diagnosis of occult (low pressure) hydrocephalus as a possible explanation for continuing headaches, gait disturbances, and failing intellectual status during the course of treatment in a patient suffering from cryptococcal meningitis or subsequent to apparent cure. In such cases a ventriculo-atrial shunt may prove most rewarding.
